ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Triphenylphosphine → Tert-butyl 4-[6-(4-cyclohexyl-3-trifluoromethyl-phenoxymethyl)-pyridin-3-yl]-piperazine-1-carboxylate

HRID 2100667
印刷

反応式

HRID 2100667 の反応式
[OH:1][CH2:2][C:3]1[N:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]2)=[CH:5][CH:4]=1.[CH:22]1([C:28]2[CH:33]=[CH:32][C:31](O)=[CH:30][C:29]=2[C:35]([F:38])([F:37])[F:36])[CH2:27][CH2:26][CH2:25][CH2:24][CH2:23]1.N(C(N1CCCCC1)=O)=NC(N1CCCCC1)=O.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>C(Cl)Cl>[CH:22]1([C:28]2[CH:33]=[CH:32][C:31]([O:1][CH2:2][C:3]3[N:8]=[CH:7][C:6]([N:9]4[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]4)=[CH:5][CH:4]=3)=[CH:30][C:29]=2[C:35]([F:36])([F:37])[F:38])[CH2:23][CH2:24][CH2:25][CH2:26][CH2:27]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 11776TriphenylphosphineHCID 730421,1'-(Azodicarbonyl)dipiperidineHCID 68814347Tert-butyl 4-(6-hydroxymethyl-pyridin-3-yl)-piperazine-1-carboxylateHCID 688157504-Cyclohexyl-3-(trifluoromethyl)phenol

生成物 1

HCID 68815760Tert-butyl 4-[6-(4-cyclohexyl-3-trifluoromethyl-phenoxymethyl)-pyridin-3-yl]-piperazine-1-carboxylate

試薬・触媒・溶媒

1
HCID 6344Dichloromethane溶媒

実験手順

tert-Butyl 4-(6-hydroxymethyl-pyridin-3-yl)-piperazine-1-carboxylate (0.22 mmol), 4-Cyclohexyl-3-trifluoromethyl-phenol (0.22 mmol, synthesized in a similar manner as described in a previous example), 1,1′-azodicarbonyl dipiperdine (0.33 mmol) and Ph3P (0.33 mmol) are mixed in DCM (2 mL). The reaction mixture is stirred at room temperature for 17 h and then partitioned between saturated Na2CO3 solution and EtOAc. The aqueous phase is extracted with EtOAc. The combined organic extracts are washed with saturated aqueous NaCl and dried over Na2SO4. After concentration, the residue is purified by silica gel chromatography (6:5 hexanes/EtOAc) to give tert-butyl 4-[6-(4-cyclohexyl-3-trifluoromethyl-phenoxymethyl)-pyridin-3-yl]-piperazine-1-carboxylate.

後処理

  1. custompartitioned between saturated Na2CO3 solution and EtOAc
  2. extractionThe aqueous phase is extracted with EtOAc
  3. washThe combined organic extracts are washed with saturated aqueous NaCl
  4. dry with materialdried over Na2SO4
  5. concentrationAfter concentration
  6. customthe residue is purified by silica gel chromatography (6:5 hexanes/EtOAc)

出典と根拠

ORDレコード
ord-5849b5898ccd4753a10c02e18f5d15c5
出典データセット
uspto-grants-2009_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07572811B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート